Dasiglucagon

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Dasiglucagon
Accession Number
DB15226
Description

Dasiglucagon is under investigation in clinical trial NCT03735225 (Evaluation of the Safety, Tolerability and Bioavailability of Dasiglucagon Following Subcutaneous (SC) Compared to IV Administration).

Type
Biotech
Groups
Investigational
Synonyms
  • Dasiglucagon

Pharmacology

Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:
Machine Learning
Data Science
Drug Discovery
Accelerate your drug discovery research with our fully connected ADMET dataset
Learn more
Indication
Not Available
Contraindications & Blackbox Warnings
Contraindications
Contraindications & Blackbox Warnings
With our commercial data, access important information on dangerous risks, contraindications, and adverse effects.
Learn more
Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects
Learn more
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Medicalerrors
Reduce medical errors
and improve treatment outcomes with our comprehensive & structured data on drug adverse effects.
Learn more
Reduce medical errors & improve treatment outcomes with our adverse effects data
Learn more
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Products
Comprehensive & structured drug product info
From application numbers to product codes, connect different identifiers through our commercial datasets.
Learn more
Easily connect various identifiers back to our datasets
Learn more
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
ZegalogueInjection, solution0.6 mg/0.6mLSubcutaneousZealand Pharma A/S2021-04-05Not applicableUS flag
ZegalogueInjection, solution0.6 mg/0.6mLSubcutaneousZealand Pharma A/S2021-04-05Not applicableUS flag

Categories

Drug Categories
Not Available
Classification
Not classified

Chemical Identifiers

UNII
AD4J2O47FQ
CAS number
1544300-84-6

References

General References
Not Available
Not Available

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
3CompletedTreatmentCongenital Hyperinsulinism1
3CompletedTreatmentHypoglycemia1
3CompletedTreatmentHypoglycemia / Type 1 Diabetes Mellitus4
3Enrolling by InvitationTreatmentCongenital Hyperinsulinism1
2CompletedTreatmentHyperinsulinemic Hypoglycemia / Postprandial Hypoglycemia1
2CompletedTreatmentHypoglycemia / Type 1 Diabetes Mellitus1
2CompletedTreatmentType 1 Diabetes Mellitus2
2Not Yet RecruitingTreatmentHypoglycemia / Type 1 Diabetes Mellitus1
2, 3CompletedTreatmentType 1 Diabetes Mellitus1
2, 3RecruitingTreatmentCongenital Hyperinsulinism1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, solutionSubcutaneous0.6 mg/0.6mL
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on May 20, 2019 15:01 / Updated on February 21, 2021 18:55